Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dimethyl fumarate

dimethyl fumarate

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of dimethyl fumarate

12 trials tracked of dimethyl fumarate: 8 in phase 3 or 4 and 4 with published results. The most-cited published study has 130 citations.

12Trials tracked
8Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 3 Phase 3 5 Phase 2 4
  1. Phase 3 A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 Completed · 130 cited
  2. Phase 3 BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS) Completed · 81 cited
  3. Phase 3 Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Completed · 53 cited
  4. Phase 3 Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS). Completed · 4 cited
  5. Phase 4 Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis Completed
  6. Phase 4 Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany Completed
Show 6 more trials
  1. Phase 4 Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera Completed
  2. Phase 3 Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Completed
  3. Phase 2 Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. Completed
  4. Phase 2 Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS Completed
  5. Phase 2 Dimethyl Fumarate for Obstructive Sleep Apnea Completed
  6. Phase 2 BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dimethyl fumarate with slow titration improves treatment satisfaction and quality of life in Iranian MS patients
Neurology Phase IV
Dimethyl fumarate with slow titration improves treatment satisfaction and quality of life in Iranian MS patients Oral Pill Beats Shots for MS Patients
A 12-month, multicenter, phase 4 observational study of 645 Iranian patients with relapsing-remitting multiple sclerosis initiating dimethyl…
An oral pill for multiple sclerosis improves sleep and mood while boosting patient satisfaction compared to monthly injections.
Apr 13, 2026